Apoptosis
Research Areas
Products Related to Apoptosis(675)
- GC74187Salicylic acid-13C6CAS: 1189678-81-6Purity: >97.00%
Salicylic acid-13C6 is the 13C-labeled Salicylic acid.
- GC74256Condurango glycoside ACAS: 11051-90-4Purity: >95.00%
Condurango glycoside A is an activator of p53.
- GC74267Propylparaben-d4CAS: 1219802-67-1Purity: >99.00%
Propylparaben-d4 is the deuterium labeled Propylparaben.
- GC74270PenduletinCAS: 569-80-2Purity: >99.00%
Penduletin is a flavone, that can be isolated from Brickelia pendula and Vitex negundo.
- GC74476SeribantumabCAS: 1334296-12-6Purity: >95.00%
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3.
- GC74477TigatuzumabCAS: 918127-53-4Purity: >95.00%
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5).
- GC74482DrozitumabCAS: 912628-39-8Purity: >99.00%
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5.
- GC74486LexatumumabCAS: 845816-02-6Purity: >96.00%
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody.
- GC74501AdebrelimabCAS: 2247114-85-6Purity: >97.00%
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody.
- GC74515BenufutamabCAS: 2109730-69-8Purity: >98.00%
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody.
- GC74538SotevtamabCAS: 2411526-47-9Purity: >99.00%
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb).
- GC74585ObexelimabCAS: 1690307-05-1Purity: >95.00%
Obexelimab (XmAb5871) is a humanized anti-CD19 antibody.
- GC74614Eftozanermin alfaCAS: 1820660-69-2Purity: >95.00%
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist.
- GC74620Zilovertamab vedotinPurity: >98.00%
Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate comprising the humanized monoclonal antibody zilovertamab and and the anti-microtubule cytotoxin monometl vedotin.
- GC746683-Methoxy-9H-CarbazoleCAS: 18992-85-3Purity: >99.00%
3-Methoxy-9H-Carbazole induces caspase-3 activities and the cellular generation of eactive oxygen species.
- GC74684Topoisomerase II inhibitor 14CAS: 305343-00-4Purity: >99.00%
Topoisomerase II inhibitor 14 (compound 2f) is a potent inhibtor of Topoisomerase II, with anticancer activity.
- GC74721Geraniol-d6 (Major)CAS: 1660976-93-1Purity: >95.00%
Geraniol-d6 (Major) is the deuterated labeled Geraniol (Major).
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC74075 | SC428 | 1898232-70-6 | >98.00% | |
SC428 is an androgen receptor (AR) inhibitor that targets the N-terminal domain. | ||||
| GC74102 | Apomine | 126411-13-0 | >99.00% | |
Apomine (SR-45023A) is an antineoplastic agent that inhibits the mevalonate/isoprenoid pathway in cholesterol synthesis. | ||||
| GC74159 | MK-0731 | 845256-65-7 | >99.00% | |
MK-0731 is a selective, non-competitive and allosteric kinesin spindle protein (KSP) inhibitor with an IC50 of 2.2 nM and a pKa of 7.6. | ||||
| GC74187 | Salicylic acid-13C6 | 1189678-81-6 | >97.00% | |
Salicylic acid-13C6 is the 13C-labeled Salicylic acid. | ||||
| GC74252 | Euphornin | 80454-47-3 | >98.00% | |
Euphornin is a anticaner agent, that can be isolated from E. helioscopia. | ||||
| GC74256 | Condurango glycoside A | 11051-90-4 | >95.00% | |
Condurango glycoside A is an activator of p53. | ||||
| GC74267 | Propylparaben-d4 | 1219802-67-1 | >99.00% | |
Propylparaben-d4 is the deuterium labeled Propylparaben. | ||||
| GC74270 | Penduletin | 569-80-2 | >99.00% | |
Penduletin is a flavone, that can be isolated from Brickelia pendula and Vitex negundo. | ||||
| GC74313 | MYBMIM | - | >99.00% | |
MYBMIM is an inhibitor for assembly of the molecular MYB:CBP/P300 complex. | ||||
| GC74476 | Seribantumab | 1334296-12-6 | >95.00% | |
Seribantumab (MM 121) is a fully human IgG2 monoclonal antibody that targets HER3. | ||||
| GC74477 | Tigatuzumab | 918127-53-4 | >95.00% | |
Tigatuzumab (CS-1008) is a humanized IgG1 monoclonal antibody targets death receptor 5 (DR5). | ||||
| GC74482 | Drozitumab | 912628-39-8 | >99.00% | |
Drozitumab (PRO 95780) is a human agonistic monoclonal antibody which binds the death receptor DR5. | ||||
| GC74486 | Lexatumumab | 845816-02-6 | >96.00% | |
Lexatumumab (HGS-ETR 2) is a human agonistic TRAIL receptor 2 (TRAIL-R2, DR5, APO-2) IgG4κ type monoclonal antibody. | ||||
| GC74501 | Adebrelimab | 2247114-85-6 | >97.00% | |
Adebrelimab (SHR-1316) is a humanized IgG4 monoclonal PD-L1 (PD-1/PD-L1) antibody. | ||||
| GC74515 | Benufutamab | 2109730-69-8 | >98.00% | |
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. | ||||
| GC74538 | Sotevtamab | 2411526-47-9 | >99.00% | |
Sotevtamab (16B5) is a humanized IgG2 anti-clusterin monoclonal antibody (mAb). | ||||
| GC74572 | Lilotomab | 1453362-55-4 | >98.00% | |
Lilotomab (0-40 µg/mL; 12 days) reduces the clonogenic survival of DOHH2 and Ramos cells. | ||||
| GC74585 | Obexelimab | 1690307-05-1 | >95.00% | |
Obexelimab (XmAb5871) is a humanized anti-CD19 antibody. | ||||
| GC74614 | Eftozanermin alfa | 1820660-69-2 | >95.00% | |
Eftozanermin alfa (ABBV-621) is a second-generation tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R) agonist. | ||||
| GC74620 | Zilovertamab vedotin | - | >98.00% | |
Zilovertamab vedotin (VLS-101) is a novel antibody-drug conjugate comprising the humanized monoclonal antibody zilovertamab and and the anti-microtubule cytotoxin monometl vedotin. | ||||
| GC74630 | TI17 | 1005178-02-8 | >97.00% | |
TI17 is an inhibitor of the troid hormone receptor-interacting protein Trip13 and has anticancer activity. | ||||
| GC74668 | 3-Methoxy-9H-Carbazole | 18992-85-3 | >99.00% | |
3-Methoxy-9H-Carbazole induces caspase-3 activities and the cellular generation of eactive oxygen species. | ||||
| GC74684 | Topoisomerase II inhibitor 14 | 305343-00-4 | >99.00% | |
Topoisomerase II inhibitor 14 (compound 2f) is a potent inhibtor of Topoisomerase II, with anticancer activity. | ||||
| GC74721 | Geraniol-d6 (Major) | 1660976-93-1 | >95.00% | |
Geraniol-d6 (Major) is the deuterated labeled Geraniol (Major). | ||||
